Oral mucosal melanoma treated with carbon ion radiotherapy: A case report

2Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Oral mucosal melanoma is a rare disease with a relatively poor prognosis. Carbon ion radiotherapy has been shown to be effective against radiotherapy-resistant tumors owing to its excellent dose concentration and high biological effect. Case presentation: Our patient was a 66-year-old Japanese man with oral mucosal melanoma of his right maxillary gingiva (T4aN0M0). He received carbon ion radiotherapy at 57.6 Gy (relative biological effectiveness) in 16 fractions for 4 weeks. Concomitant chemotherapy (dacarbazine + nimustine + vincristine) was administered at the same time as carbon ion radiotherapy initiation. Two courses of adjuvant chemotherapy were given after carbon ion radiotherapy. Although he experienced grade 2 acute oral mucositis, his symptoms improved within a few weeks of undergoing carbon ion radiotherapy. He was alive at the time of reporting, 35 months after treatment, without any recurrence. Late toxicity has not been observed. Conclusions: Carbon ion radiotherapy for oral mucosal melanoma resulted in a good local effect.

Cite

CITATION STYLE

APA

Musha, A., Saitoh, J. I., Shirai, K., Yokoo, S., Ohno, T., & Nakano, T. (2016). Oral mucosal melanoma treated with carbon ion radiotherapy: A case report. Journal of Medical Case Reports, 10(1). https://doi.org/10.1186/s13256-016-1071-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free